The kidneys have often been the poor relations of other organs in the history of medicine. Hearts, lungs, brains, and reproductive and digestive organs have received much more attention. But, as Stephen Peitzman points out, the kidneys are of such fundamental importance that when they cease to do their job, the other organs do not function properly.

Although nephrology is a relatively new clinical specialty, medical concern with kidney disease has a much longer history. Peitzman\'s wonderfully evocative history of end-stage kidney disease explores this history with verve and insight. His story proper begins with Richard Bright (1789--1858) and the disease that carried his name until recent times. One of the "Great Men of Guy\'s", Bright convinced the governors of Guy\'s Hospital, London, to devote a small ward with an attached laboratory, so he could study dropsy and the other consequences of failed kidneys. He identified the presence of albumen in the urine as a marker of kidney disease, and used both the insights of contemporary chemistry and the pathological orientation of French hospital medicine to describe a "new" disease.

Like many of his contemporaries, Bright dealt in both the ward and the autopsy room with the final results of fatal disease, correlating the findings at autopsy with the clinical diagnosis. Bright\'s work was subsequently duplicated by other pathologically orientated clinicians and, well into the twentieth century, "Bright\'s disease" carried specific, grim connotations. Its aetiology remained elusive, and most debate centred around minor modifications of treatment and management.

From the late nineteenth century, new diagnostic procedures were developed, and these, combined with a greater understanding of the physiology of the kidney, led to a reconceptualization of "Bright\'s disease". Although the eponym disappeared only gradually, doctors recognized that there were many routes to end-stage kidney disease. Management also improved, but the prognosis remained pretty much as grim as it was in Bright\'s day, with the proviso that doctors realized that in some patients, their kidney failure was temporary and with decent management, they could recover. That put a higher premium on finding ways to keep people alive, hoping that the process that had shut down their kidney function would be a reversible one.

This was the rationale for the early work on dialysis, pioneered in the Netherlands in the horrible conditions of the Second World War. Willem Kolff, the inventor of dialysis, went to the United States after the war, but his first patients were kept alive with varying degrees of success in the stressed social ambience of a Nazi-occupied country. Dialysis can be done in two ways. The common one nowadays is via a shunt in an artery, whereby the blood circulates through the dialysis machine, which removes many of the substances that the kidney ordinarily does. Urea is the most obvious of these. The problems of this form of renal dialysis were mostly technical, especially that of constructing an aterio-venous shunt that could be used without the opening clotting or getting contaminated between dialyses, which need to take place about three times a week.

The other way to dialyse a patient in kidney failure is to place a needle in the abdomen and by introducing appropriate fluids into it, allow diffusion of the waste substances to accumulate in the abdominal space. These are then removed. Peritoneal dialysis, as it is called, takes longer and also has the problems of introducing infection as well the considerable discomfort it causes. It is the kind of dialysis I remember, when I spent a month of my internship tending patients who had had problems with their shunts.

Peitzman pays only modest attention to peritoneal dialysis, since most dialysis since the mid-1970s has been via the machine. He writes movingly about both patients and their doctors in the ménage-à-trois (patients, dialysis machines and doctors), and analyses the curious trajectory of laissez-faire American medicine, whereby end-stage renal disease (ESRD) acquired the right to treatment, at public expense. Creating an entitlement to publicly funded care on the basis of a diagnosis remains unique in the American setting, where so much public medical care is either means or age tested.

Dialysis, even if someone else pays, is a terrible commitment of three or more four-hour sessions each week just to maintain some semblance of normalcy, and there is the constant threat of complications. There are also real problems with renal transplantation, but for many, that procedure offers the best hope for normal kidney function, and through that, normal social life. Peitzman takes his readers through both the science and the clinical and ethical issues of transplantation. As a nephrologist himself, he knows the medicine from the inside, and has great empathy for the patients he has spent his professional career treating. His mix of science and suffering makes for a fine book, always readable and often moving.
